ACRO Biomedical Co., Ltd. (TPEX:6748)

ACRO Biomedical Revenue

In the year 2025, ACRO Biomedical had annual revenue of 38.26M TWD, down -13.51%. ACRO Biomedical had revenue of 24.94M in the half year ending December 31, 2025, a decrease of -29.27%.

• Revenue: 38.26M
• Revenue Growth: -13.51%
• P/S Ratio: 138.88
• Revenue / Employee: n/a
• Employees: 34
• Market Cap: 5.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	38.26M	-5.98M	-13.51%
Dec 31, 2024	44.23M	-6.83M	-13.38%
Dec 31, 2023	51.06M	23.43M	84.79%
Dec 31, 2022	27.63M	5.81M	26.59%
Dec 31, 2021	21.83M	3.80M	21.04%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 29, 2026

Data Sources Report a data error